Literature DB >> 18359220

Hope in advanced cancer patients.

Susan E McClement1, Harvey Max Chochinov.   

Abstract

Individuals diagnosed with advanced cancer frequently experience physical and psychological distress. Hope has been identified as an essential resource in the lives of people with cancer, helping them to cope during times of suffering and uncertainty. Therefore, in order to help bolster hope, health care providers require an understanding of its meaning from the perspective of advanced cancer patients and an awareness of those interventions demonstrated empirically to foster hope in this patient population. This paper summarises salient evidence pertaining to hope in advanced cancer patients and their families or informal caregivers. We examine the challenging issue of how to define hope, discuss the issue of measuring hope and review the state of evidence addressing interventions that may enhance or bolster hope in the face of advanced disease.

Entities:  

Mesh:

Year:  2008        PMID: 18359220     DOI: 10.1016/j.ejca.2008.02.031

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  32 in total

1.  The family's experience of the child and/or teenager in palliative care: fluctuating between hope and hopelessness in a world changed by losses.

Authors:  Maira Deguer Misko; Maiara Rodrigues dos Santos; Carolliny Rossi de Faria Ichikawa; Regina Aparecida Garcia de Lima; Regina Szylit Bousso
Journal:  Rev Lat Am Enfermagem       Date:  2015 May-Jun

Review 2.  Conceptualizing prognostic awareness in advanced cancer: a systematic review.

Authors:  Allison J Applebaum; Elissa A Kolva; Julia R Kulikowski; Jordana D Jacobs; Antonio DeRosa; Wendy G Lichtenthal; Megan E Olden; Barry Rosenfeld; William Breitbart
Journal:  J Health Psychol       Date:  2013-10-24

Review 3.  Through the patient's eyes: the value of a comprehensive brain tumor center.

Authors:  Adam M Robin; Tobias Walbert; Tom Mikkelsen; Steven N Kalkanis; Jack Rock; Ian Lee; Mark L Rosenblum
Journal:  J Neurooncol       Date:  2014-07-16       Impact factor: 4.130

4.  Faith and protection: the construction of hope by parents of children with leukemia and their oncologists.

Authors:  Peter Salmon; Jonathan Hill; Joanne Ward; Katja Gravenhorst; Tim Eden; Bridget Young
Journal:  Oncologist       Date:  2012-02-27

5.  Enhanced conscious processing and blindsight-like detection of fear-conditioned stimuli under continuous flash suppression.

Authors:  Joana B Vieira; Sophia Wen; Lindsay D Oliver; Derek G V Mitchell
Journal:  Exp Brain Res       Date:  2017-08-16       Impact factor: 1.972

6.  On sinking and swimming: the dialectic of hope, hopelessness, and acceptance in terminal cancer.

Authors:  Emily Sachs; Elissa Kolva; Hayley Pessin; Barry Rosenfeld; William Breitbart
Journal:  Am J Hosp Palliat Care       Date:  2012-05-02       Impact factor: 2.500

7.  Ultimate journey of the terminally ill: Ways and pathways of hope.

Authors:  Serge Daneault; Véronique Lussier; Suzanne Mongeau; Louise Yelle; Andréanne Côté; Claude Sicotte; Pierre Paillé; Dominique Dion; Manon Coulombe
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

8.  Odyssey of hope: a physician's guide to communicating with brain tumor patients across the continuum of care.

Authors:  Mark L Rosenblum; Steven Kalkanis; Wendy Goldberg; Jack Rock; Tom Mikkelsen; Sandra Remer; Sarah Whitehouse; David Nerenz
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.

Authors:  Fiona A Miller; Robin Z Hayeems; Jessica P Bytautas; Philippe L Bedard; Scott Ernst; Hal Hirte; Sebastien Hotte; Amit Oza; Albiruni Razak; Stephen Welch; Eric Winquist; Janet Dancey; Lillian L Siu
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

Review 10.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.